Nashville, Tenn. – September 11, 2026 -- EvidenceCare has named John Voigt Jr. as its first unified Chief Revenue Officer, consolidating sales and marketing under one executive as the clinical performance improvement platform enters its next growth phase.
Voigt brings a track record of scaling healthcare technology revenue functions
Voigt previously served as executive vice president of growth and strategy at ActiumHealth (Syllable AI), where he led commercial strategy for the company's AI-driven patient access platform. Before that, he directed health system growth strategy at Wellvana Health, building partnerships that generated more than $200 million in annual risk revenue. Earlier in his career, he helped grow Cedar's annual recurring revenue from $2 million to over $85 million.
EvidenceCare consolidates sales and marketing to unify growth strategy
Bo Bartholomew, CEO and Chairman of EvidenceCare, said the company combined sales and marketing under a single leader because its next growth stage requires both functions aligned. Voigt will own EvidenceCare's revenue strategy end to end as the company's sole accountable executive for growth.
New CRO frames physician trust as foundation for revenue expansion
Voigt said EvidenceCare has spent a decade earning physician trust, a factor he called critical as AI becomes more embedded in clinical decision-making. He holds a bachelor's degree in international relations and political science from Muhlenberg College and is based in Nashville.